Clinical effects of “pioglitazone”, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trial | Mona Abdel-Halim

Clinical effects of “pioglitazone”, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trial

Citation:: Hafez, V. G., M. Bosseila, M. R. E. Abdel Halim, O. G. Shaker, M. Kamal, and H. S. Kareem, "Clinical effects of “pioglitazone”, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trial", Journal of Dermatological Treatment, vol. 26 (3), issue Jun: Informa UK Ltd. London, pp. 208-14, 2015.

Abstract:

n/a

Notes:

n/a